Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IntellxxDNA is a health technology company that provides clinicians with advanced genomic clinical decision support tools designed to facilitate personalized medicine. The company's platform analyzes complex gene-gene interactions and Single Nucleotide Polymorphisms (SNPs) to provide highly detailed medical insights and evidence-based intervention strategies. Unlike standard direct-to-consumer tests, IntellxxDNA focuses on functional medicine, offering specialized reports in areas such as cognitive health, cardiovascular wellness, and pediatric development. By bridging the gap between genomic research and clinical practice, the company enables healthcare providers to develop targeted prevention and treatment plans tailored to a patient's unique genetic profile. Their products are exclusively available through licensed healthcare professionals to ensure proper clinical interpretation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IntellxxDNA.